CN114767590B - Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof - Google Patents
Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof Download PDFInfo
- Publication number
- CN114767590B CN114767590B CN202210420975.4A CN202210420975A CN114767590B CN 114767590 B CN114767590 B CN 114767590B CN 202210420975 A CN202210420975 A CN 202210420975A CN 114767590 B CN114767590 B CN 114767590B
- Authority
- CN
- China
- Prior art keywords
- acne
- scar
- extract
- percent
- cosmetic liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 60
- 206010000496 acne Diseases 0.000 title claims abstract description 60
- 239000007788 liquid Substances 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 231100000241 scar Toxicity 0.000 claims abstract description 53
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000002537 cosmetic Substances 0.000 claims abstract description 44
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 35
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 18
- 241001546929 Campsis grandiflora Species 0.000 claims abstract description 18
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 18
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 18
- 229960002216 methylparaben Drugs 0.000 claims abstract description 18
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 18
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims abstract description 18
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims abstract description 17
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 17
- 229920001577 copolymer Polymers 0.000 claims abstract description 17
- 229960002648 alanylglutamine Drugs 0.000 claims abstract description 16
- 108010044940 alanylglutamine Proteins 0.000 claims abstract description 16
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims abstract description 15
- 229960005150 glycerol Drugs 0.000 claims abstract description 15
- 235000011187 glycerol Nutrition 0.000 claims abstract description 15
- 229960003415 propylparaben Drugs 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 14
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 230000019612 pigmentation Effects 0.000 claims abstract description 9
- 230000008439 repair process Effects 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 206010020718 hyperplasia Diseases 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 5
- 206010011732 Cyst Diseases 0.000 claims description 3
- 208000031513 cyst Diseases 0.000 claims description 3
- 230000036573 scar formation Effects 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- UEFYOKRTWUGUPT-UHFFFAOYSA-N 2,3-dihydroxypropanoic acid;prop-2-enoic acid Chemical compound OC(=O)C=C.OCC(O)C(O)=O UEFYOKRTWUGUPT-UHFFFAOYSA-N 0.000 claims 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 claims 1
- 229920006222 acrylic ester polymer Polymers 0.000 claims 1
- -1 propylene diglycerol acrylate Chemical compound 0.000 abstract description 12
- 206010039580 Scar Diseases 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 22
- 208000032544 Cicatrix Diseases 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 230000037387 scars Effects 0.000 description 14
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000005096 rolling process Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 8
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 8
- 229940022757 asiaticoside Drugs 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 238000012372 quality testing Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 229910052727 yttrium Inorganic materials 0.000 description 4
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 4
- 206010006784 Burning sensation Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 238000001728 nano-filtration Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 206010000503 Acne cystic Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of cosmetic preparations, and particularly relates to a scar and acne mark removing cosmetic liquid and a preparation method and application thereof. The invention relates to a scar and acne mark removing cosmetic liquid, which comprises the following raw materials in parts by weight: centella asiatica extract, honeysuckle extract, campsis grandiflora extract, alanyl glutamine, propylene diglycerol acrylate/acrylic acid copolymer, PVM/MA copolymer, glycerin, methylparaben, propylparaben and deionized water. The scar-removing acne mark-removing cosmetic liquid provided by the invention can effectively resist inflammation, inhibit formation and proliferation of acne scars and soften formed old acne marks, can repair red blood streaks and acne mark pigmentation, and has a skin water locking function.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a scar and acne mark removing cosmetic liquid and a preparation method and application thereof.
Background
Acne is well-developed on the face and chest and back, and is a Mao Zhouyan skin disorder due to excessive sebum secretion, obstruction of the pilosebaceous ducts, and Mao Cuochuang propionibacteria. About 80% -90% of people except children suffer from the disease or have suffered from acne. Inflammatory healing tends to leave behind scars, mainly pigmentation and pitting scars, which are classified internationally into boxcar type scars, rolling type scars, ice cone type scars. The facial acne scars can affect the mind of people, so that many people can spell because of the acne scars, and also many people lose the free selection work and select the right of marital, and as such, the positive treatment of the acne scars is particularly important.
The traditional Chinese patent medicine for treating acne scars is mainly asiaticoside cream and is widely applied to clinic. The roller pin of the micro needle is very fine, the roller is fully covered with fine needles with the diameter of 0.5mm-2mm, and when the roller pin rolls on the skin, the micro needle head is utilized to puncture the skin for a plurality of times, so that micropores penetrating through the dermis are generated. Wounds initiate wound healing and growth factor release in the dermis, which allows collagen to be produced and deposited on the upper dermis. The micro needle has definite curative effect on acne sinking type scars, especially on boxcar type scars and rolling type scars, can stimulate the regeneration of facial collagen, and has certain full face beautifying and lifting effects. The asiaticoside ointment combined with the microneedle has been clinically applied to acne, but the ointment is thick and greasy in body, poor in comfort and easy to have reactions such as redness, swelling and discomfort on the face after administration. In addition, the microneedles have the problems of skin dryness sensitivity, even active dry streak, local color deposition, uneven skin color and the like in a period of time after treatment, pain and discomfort in the operation process and the like.
The beauty liquid which has fresh texture, definite curative effect of removing scars and acne marks, can relieve pain and burning sensation in the microneedle treatment process and reduce side effects of microneedle treatment is developed, and has very important significance.
Disclosure of Invention
In order to overcome the problems in the prior art, the invention aims to provide a scar and acne mark removing cosmetic liquid and a preparation method and application thereof.
In order to achieve the above and other related objects, the present invention adopts the following technical scheme:
the invention provides a scar and acne mark removing cosmetic liquid, which comprises the following raw materials in parts by weight: centella asiatica extract, honeysuckle extract, campsis grandiflora extract, alanyl glutamine, propylene diglycerol acrylate/acrylic acid copolymer, PVM/MA copolymer, glycerin, methylparaben, propylparaben and deionized water.
In some preferred embodiments, the weight percentages of the component raw materials are: 3.5 to 20 percent of centella asiatica extract, 1.5 to 10 percent of honeysuckle extract, 1.5 to 10 percent of campsis grandiflora extract, 5.0 to 20.0 percent of alanyl glutamine, 15 to 55 percent of propylene diglycerol acrylate/acrylic acid copolymer, 1.0 to 4.0 percent of PVM/MA copolymer, 0.1 to 1.0 percent of glycerol, 0.01 to 0.15 percent of methylparaben, 0.01 to 0.05 percent of propylparaben and 35 to 55 percent of deionized water.
In some preferred embodiments, the weight percentages of the component raw materials are: 5-15% of centella asiatica extract, 2-5% of honeysuckle extract, 3-5% of campsis grandiflora extract, 8.0-15.0% of alanyl glutamine, 20-30% of malonyl acrylate/acrylic acid copolymer, 2.0-3.0% of PVM/MA copolymer, 0.1-0.5% of glycerin, 0.02-0.1% of methylparaben, 0.03-0.05% of propylparaben and 40.0-50.0% of deionized water.
In some preferred embodiments, the weight percentages of the component raw materials are: 10% of centella asiatica extract, 3.5% of honeysuckle extract, 3.5% of campsis grandiflora extract, 10% of alanyl glutamine, 25% of propylene diglycerol acrylate/acrylic acid copolymer, 2.0% of PVM/MA copolymer, 0.5% of glycerol, 0.05% of methylparaben, 0.03% of propylparaben and 45.42% of deionized water.
In a second aspect of the present invention, a preparation method of the aforementioned scar-removing acne mark-removing cosmetic liquid is provided, comprising the following steps:
s1, stirring centella asiatica extract, honeysuckle extract, campsis grandiflora extract and alanyl glutamine to obtain a first mixture;
s2, stirring the propylene diglycerol acrylate/acrylic acid copolymer, the PVM/MA copolymer, glycerol, methylparaben, propylparaben and deionized water to obtain a second mixture;
and S3, mixing the first mixture obtained in the step S1 and the second mixture obtained in the step S2, and stirring the mixture uniformly to obtain the scar and acne mark removing cosmetic liquid.
In some preferred embodiments, the stirring speed in step S1 is 60 to 150rpm and the stirring time is 0.5 to 1h.
In some preferred embodiments, the stirring speed in step S2 is 100-200 rpm and the stirring time is 0.5-1 h;
in some preferred embodiments, the stirring speed in step S3 is 100 to 200rpm and the stirring time is 0.5 to 1h.
In a third aspect, the invention provides an application of the scar and acne mark removing cosmetic liquid in scar and acne mark removing.
In a fourth aspect, the invention provides the use of the scar-removing acne mark-removing cosmetic liquid in preparing a medical or cosmetic product for scar repair or acne mark removal.
In a fifth aspect, the present invention provides the use of the aforementioned scar-removing acne mark-removing cosmetic liquid for preparing a cosmetic product having any one of the following effects: 1) Skin pit scar repair; 2) Acne print pigmentation is reduced; 3) Cyst type acne detumescence and stagnation elimination; 4) Inhibit acne scar formation and hyperplasia.
In a sixth aspect, the invention provides an application of the scar and acne mark removing cosmetic liquid in preparing a microneedle base liquid.
In a seventh aspect, the present invention provides a cosmetic product for removing scars and acne marks, comprising the cosmetic liquid.
According to an eighth aspect of the present invention, there is provided a method for using the above-mentioned cosmetic liquid, comprising the steps of:
(a) Sterilizing the face of the patient before use;
(b) Selecting 0.5-1.0 mm sterile roller pin, interleaving and rolling for 3-5 times in all directions of local skin, and applying the cosmetic liquid while rolling until swelling of local skin is finished.
The beautifying liquid provided by the invention is matched with microneedle therapy, is beneficial to the introduction of effective components of the liquid, enhances the effect after use, and has better effect compared with direct coating.
Compared with the prior art, the invention has the following beneficial effects:
1. the scar-removing acne mark-removing cosmetic liquid provided by the invention has the synergistic effect of all the components, can inhibit scar hyperplasia, lighten pigmentation, simultaneously has the effects of resisting inflammation and easing pain, and has the effects of clearing heat and relieving pain, preserving moisture and locking water, and is suitable for being used as a base liquid for microneedle treatment.
2. The scar-removing acne mark-removing cosmetic liquid provided by the invention has obvious treatment effects on scars and acne marks, can obviously improve the scar depression degree of patients, improves the skin appearance flatness, reduces acne mark pigmentation, promotes cyst type acne to reduce swelling and dissipate stagnation, inhibits acne scar formation and hyperplasia, can reduce the side effect of slight needle treatment when used as a microneedle base liquid, has better curative effect than asiaticoside ointment, and has good clinical application value.
Drawings
FIG. 1 is a photograph of a typical case 1 with a file left on the affected area before treatment.
FIG. 2 is a photograph of the affected area after treatment of typical case 1.
FIG. 3 is a photograph of a typical case 2 with a file left on the affected area before treatment.
Fig. 4 is a photograph of the affected part after the treatment of typical case 2.
Fig. 5 is a photograph of a typical case 3 with a file left on the affected part before treatment.
Fig. 6 is a photograph of the affected part after the treatment of typical case 3.
FIG. 7 is a photograph of a typical case 3 with a file left on the affected area before the second treatment.
FIG. 8 is a photograph of the affected area after the secondary treatment of typical case 3.
Detailed Description
The centella asiatica extract is used as the main component of the beauty treatment liquid, and the asiaticoside contained in the centella asiatica extract has the effects of clearing heat, promoting diuresis, removing toxicity and eliminating carbuncles, can inhibit scar hyperplasia, lighten pigmentation, is easy to permeate skin and has fresh and cool texture; meanwhile, the honeysuckle extract and the campsis grandiflora extract are added, and the honeysuckle extract and the campsis grandiflora extract are synergistic in anti-inflammation and reddening, calm and ease, so that the problem of skin redness and swelling sensitivity after rolling can be effectively relieved; the oligopeptide-1 and oligopeptide-3 in alanyl glutamine (lipeptide) are hydrolyzed to generate L-glutamine, which can promote the LXR activity in main keratinocytes of human body and the activation of epidermis lipid synthase, improve the hydration of skin, be beneficial to skin aging and have good water locking function; the polyvinyl formal/methyl acrylate copolymer (PVM/MA copolymer) has certain lubrication thickening property, and is used together with the active ingredients, so that the moisturizing property of the beautifying liquid is enhanced, and the pain and burning sensation in the process can be effectively relieved when the beautifying liquid is used as a base liquid for microneedle treatment, and the pain of a patient is relieved.
Propylene diglycerol acrylate/acrylic acid copolymer: commercially available cosmetic raw materials. Can be used as thickener, viscosity control agent and humectant, and can give fluidity and transparency to skin care liquid, and is mild and has no irritation.
PVM/MA copolymer: commercially available cosmetic raw materials. It is used as antistatic agent, binder and emulsion stabilizer in cosmetics.
Glycerol: the chemical name is glycerol, is colorless, odorless and sweet viscous liquid, has strong water absorption, and can be applied on skin to moisten skin without chapping. The glycerin is absorbed quickly, and the skin peeled by changing seasons, acne scars, sensitive skin and the like are all excellent moisturizing products, so that the skin can be kept soft and elastic, and is not damaged by dust, climate and the like and is dried.
Methylparaben: the chemical name is methyl parahydroxybenzoate, also called methylparaben or methylparaben, is an organic matter, and the chemical formula is C 8 H 8 O 3 White crystalline powder or colorless crystals, which have the property of being easily dissolved in alcohol, ether and acetone, and being very slightly dissolved in water, and the boiling point is 270-280 ℃. The organic antiseptic is mainly used as an antiseptic for organic synthesis, food, cosmetics and medicines, and also used as a feed antiseptic.
Propyl paraben: the chemical name is propyl p-hydroxybenzoate, also known as propyl p-hydroxybenzoate or propyl p-hydroxybenzoate, is an organic matter, and the chemical formula is C 10 H 12 O 3 White crystalline powder, having the property of being easily soluble in alcohols, ethers and acetone, and slightly soluble in water, with a boiling point of 133 ℃. Is mainly used for organic synthesis, food, cosmetics and medicineIs also used as a feed preservative.
Before the embodiments of the invention are explained in further detail, it is to be understood that the invention is not limited in its scope to the particular embodiments described below; it is also to be understood that the terminology used in the examples of the invention is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the invention. The test methods in the following examples, in which specific conditions are not noted, are generally conducted under conventional conditions or under conditions recommended by the respective manufacturers.
Where numerical ranges are provided in the examples, it is understood that unless otherwise stated herein, both endpoints of each numerical range and any number between the two endpoints are significant both in the numerical range. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In addition to the specific methods, devices, materials used in the embodiments, any methods, devices, and materials of the prior art similar or equivalent to those described in the embodiments of the present invention may be used to practice the present invention according to the knowledge of one skilled in the art and the description of the present invention.
Unless otherwise indicated, the experimental methods, detection methods, and preparation methods disclosed in the present invention all employ techniques conventional in the art.
Example 1
The scar and acne mark removing cosmetic liquid comprises the following raw materials in percentage by weight: centella asiatica extract 7.0%, honeysuckle flower extract 3.0%, campsis grandiflora extract 5.0%, alanyl glutamine 8.0%, propylene diglycerol acrylate/acrylic acid copolymer 20%, PVM/MA copolymer 2.5%, glycerin 0.6%, methylparaben 0.10%, propylparaben 0.02% and deionized water 53.78%.
Example 2
The scar and acne mark removing cosmetic liquid comprises the following raw materials in percentage by weight: 10% of centella asiatica extract, 3.5% of honeysuckle extract, 3.5% of campsis grandiflora extract, 10% of alanyl glutamine, 25% of propylene diglycerol acrylate/acrylic acid copolymer, 2.0% of PVM/MA copolymer, 0.5% of glycerol, 0.05% of methylparaben, 0.03% of propylparaben and 45.42% of deionized water.
Example 3
The scar and acne mark removing cosmetic liquid comprises the following raw materials in percentage by weight: 15% of centella asiatica extract, 6.0% of honeysuckle extract, 6.5% of campsis grandiflora extract, 5% of alanyl glutamine, 15% of propylene diglycerol acrylate/acrylic acid copolymer, 3.0% of PVM/MA copolymer, 0.8% of glycerol, 0.15% of methylparaben, 0.05% of propylparaben and 48.5% of deionized water.
Clinical application
1. Study object: the medical college of Shanghai communication is affiliated to the medical department of beauty of traditional Chinese medicine department of south China of the ninth people's hospital, and meets the diagnosis standard and inclusion standard. 60 acne vulgaris scar patients were selected. The scar area is 2cm minimum and 42cm maximum, wherein the scar is mainly 14 cases of ice cone type scars, 27 cases of rolling type scars and 49 cases of box type scars. 30 treatment groups, 2 men and 28 women, were aged 21 years minimum and 35 years maximum. 30 treatment groups, 1 male and 29 female, were aged at least 19 years and at most 34 years, and there was no statistical significance of the difference between the gender and age of the two groups (P > 0.05). Exclusion criteria patients had a recent history of light sensitive drugs, a history of solar insolation, mental abnormalities, pregnant women, and scar constitutions.
2. Cosmetic liquid preparation
2.1 major component manufacturers and product numbers
Centella asiatica extract: YH-51512, a product of Shanghai yttrium Lang chemical technology Co., ltd. The solid content is more than 3.5%, and the main medicinal components are asiaticoside, madecassoside, asiatic acid and madecassic acid. The pharmacological action has inhibiting effect on staphylococcus aureus, hemolytic streptococcus, various dysentery bacillus and typhoid bacillus, and also has influence on scar fibroblast activity. Is clinically used for promoting wound healing and inhibiting scar hyperplasia. The extraction process comprises the following steps: 1. cleaning centella asiatica, crushing 2.1,3 propylene glycol, heating and extracting 3, filtering (300-mesh filter screen) 4, filtering 5, filtering by paper 6, heating and concentrating 7, quality testing 8, freezing 9, thawing and adjusting (PH adjusting and the like) 10, nanofiltration 11, sterilizing 12, preserving 13, quality testing 14 and packaging.
Campsis grandiflora extracting solution: YH-52868 is a product of Shanghai yttrium Lang chemical technology Co. The solid content is 3.5% -10%, and the main medicinal components are triterpenes, flavonoids, anthocyanidins, volatile oil and the like. The pharmacological effects have effects of improving blood circulation, inhibiting thrombosis, relieving pain, relieving inflammation, and resisting oxidation. Clinically used for treating dermatosis such as acne, hormone dependent dermatitis, etc. The extraction process comprises the following steps: 1. cleaning campsis grandiflora, crushing 2.1,3 propylene glycol, heating and extracting 3, filtering (300-mesh filter screen) 4, filtering by cloth 5, filtering by paper 6, heating and concentrating 7, quality testing 8, freezing 9, thawing and adjusting (pH adjusting and the like) 10, nanofiltration 11, sterilizing 12, preserving 13, quality testing 14 and packaging.
Honeysuckle extract: YH-51120, a product of Shanghai yttrium Lang chemical technology Co., ltd. The solid content is 3.5% -10%, and the main medicinal components are volatile oil, organic acids, flavonoids, iridoid glycosides, triterpenoid saponins and the like. Pharmacological actions of clearing heat and detoxicating, cooling and dispelling wind-heat. The clinical application is as follows: carbuncle and swelling can be caused by sore, sore throat, erysipelas. The extraction process comprises the following steps: 1. cleaning honeysuckle, crushing 2.1,3 propylene glycol, heating and extracting 3, filtering (300-mesh filter screen) 4, cloth filtering 5, paper filtering 6, heating and concentrating 7, quality inspection 8, freezing 9, thawing adjustment (pH adjustment and the like) 10, nanofiltration 11, sterilization 12, preservation 13, quality inspection 14 and packaging.
Lipeptide essence powder: yttrium over sea enamel chemical technology limited. Chinese name: alanylglutamine, INCI name ALANYL GLUTAMINE, CAS No.39537-23-0. The product is white to pale yellow powder, is soluble in water, and has stable properties at normal temperature. Wherein the content of oligopeptide-1 is 35wt%, and the content of oligopeptide-3 is 20wt%, and the composition has the effects of resisting oxidation, delaying skin aging, promoting tissue repair, and moisturizing and locking water.
2.2 preparation method
The cosmetic liquid is prepared according to the following steps:
step one, mixing the centella asiatica extract, the honeysuckle extract, the campsis grandiflora extract and the Lipeptide essence powder, and stirring at a speed of 100rpm for 1h to obtain a first mixture;
step two, mixing the propylene diglycerol acrylate/acrylic acid copolymer, PVM/MA copolymer, glycerol, methylparaben and propylparaben, adding deionized water, and stirring at 130rpm for 1h to obtain a second mixture;
and step three, mixing the first mixture obtained in the step one and the second mixture obtained in the step two, and stirring at 180rpm, and uniformly mixing to obtain the scar and acne mark removing cosmetic liquid.
The beauty lotion prepared by the method comprises the following components in percentage by weight: 10% of centella asiatica extract, 3.5% of honeysuckle extract, 3.5% of campsis grandiflora extract, 10% of alanyl glutamine, 25% of propylene diglycerol acrylate/acrylic acid copolymer, 2.0% of PVM/MA copolymer, 0.5% of glycerol, 0.05% of methylparaben, 0.03% of propylparaben and 45.42% of deionized water.
3. Preoperative preparation
The medical staff before treatment can communicate with the patient fully, introduce the treatment method, the intraoperative notice and the emergency prevention method to the patient, and reduce the psychological pressure of the patient so as to obtain the coordination and understanding of the patient. At the same time, the face of the patient is cleaned before operation and photographed under the same light source for reservation.
4. Therapeutic method
The face disinfectant of the treatment group is disinfected. The microneedle therapy selects a sterile rolling needle with the thickness of 0.5mm to 1.0mm, the prepared cosmetic liquid is held by a left hand, the cosmetic liquid is staggered and rolled for 3 to 5 times in all directions of local skin, and the cosmetic liquid is smeared while rolling until the local skin is swollen as a treatment end point. The treated area was inhibited from contacting raw water for 24 hours after treatment, and care was taken for moisture retention and sun protection. Treatment is carried out for 1-6 times, 2 times per month.
The facial disinfectant of the control group was sterilized. The microneedle therapy selects a sterile roller needle with the thickness of 0.5mm-1.0mm, and the roller needle is staggered and rolled for 3-5 times in all directions of local skin until swelling of the local skin appears as a treatment end point. After the treatment is finished, the asiaticoside ointment is smeared on the scar, and the treated part is forbidden to contact with raw water within 24 hours after the smearing treatment, and the moisture preservation and the sun protection are paid attention to. Treatment is carried out for 1-6 times, 2 times per month.
5. Therapeutic results
5.1 Standard of efficacy
(1) And (3) healing: the repair degree of scar recess of the patient reaches 90%;
(2) The effect is shown: the repairing degree of the scar recess of the patient reaches 60 percent, the appearance is smooth, and the uneven color is obviously reduced;
(3) The method is effective: the repairing degree of scar recess of the patient is 30-59%, the appearance is improved to a certain extent, and uneven color is obviously reduced;
(4) Invalidation: the scar recession degree is repaired to be lower than 30%, and the appearance is not changed or even aggravated.
Total effective rate= (number of recovery cases + number of significant cases + number of effective cases)/total case number x 100%.
5.2 subjective satisfaction surveys of patients. According to subjective evaluation of patients on satisfaction and treatment experience of treatment effect, indexes are divided into very satisfactory, satisfactory and unsatisfactory in sequence, and the satisfaction rate= (very satisfactory+satisfactory)/number of cases is multiplied by 100%.
5.3 comparing the occurrence of the two groups of adverse reactions. Common adverse reactions are facial infection, skin allergy or sensitivity, color sinking, others (color sinking, acne, erythema edema).
5.4 statistical analysis
Study data were analyzed using SPSS 22.0, and count data was expressed as percent (%), row χ 2 And (5) checking. P is less than 0.05, and the prompt difference has statistical significance.
5.5 results
5.5.1 therapeutic effects are shown in Table 1 below:
table 1 comparison of the efficacy of two groups of patients
Note that: x-shaped articles 2 =7.34 1) P<The effective rate of the 0.05 treatment group is higher than that of the control group.
As shown by the statistical results in Table 1, the curative effect of the cosmetic liquid provided by the invention for treating scar recess and acne mark by matching with the rolling needle is superior to that of asiaticoside ointment, and the cosmetic liquid provided by the invention has good scar and acne mark removing effect.
5.5.2 adverse reaction observations
Table 2 comparison of adverse effects in two groups of patients
Note that: x-shaped articles 2 =5.24P<Adverse events were lower in the 0.05 treatment group than in the control group.
As shown by the statistical results in Table 2, the adverse reaction rate of the cosmetic liquid provided by the invention for treating scar recess and acne mark by matching with the needle roller is lower than that of asiaticoside ointment, which indicates that the cosmetic liquid provided by the invention can reduce the side effect of microneedle treatment.
5.5.3 satisfaction survey
The satisfaction degree of the treatment group patients on the treatment effect is 95.53 percent, which is obviously higher than that of the control group 76.47 percent, and the difference has statistical significance (P is less than 0.05). The satisfaction degree of the treatment group patients on the treatment experience is 93.33%, which is obviously higher than that of the control group 66.67%, and the difference has statistical significance (P is less than 0.05). In the treatment experience satisfaction investigation process, the VRS method is adopted to enable the treatment group patients and the control group patients to evaluate pain and burning sensation in the treatment process respectively, the treatment group patients evaluate 19 cases of mild pain and 11 cases of moderate pain, and the control group patients evaluate 5 cases of mild pain, 18 cases of moderate pain and 7 cases of severe pain.
Typical cases
Case 1: aged somewhere, women, 30 years old, and staff in Shanghai hospitals. For repeated acne for three months, the treatment is carried out in the hospital in the year 2020 at 11 after the pigment scar is left for 1 month, and fig. 1 is a photograph of the treatment before the treatment; the scar and acne mark removing beautifying liquid is matched with the needle roller for treatment, and the treatment is carried out once per week for 4 times. Fig. 2 is a photograph of a post-treatment residue, in which a number of acne marks on the cheek are visibly pale in color, partially disappeared, and fair and firm in facial skin than before.
Case 2: some sun, some woman, 27 years old, shanghai is on duty. For many years, acne was followed by the subsequent rough skin with pigmentation after topical hormonal medications were administered. Treatment in China is 11 months in 2020, and fig. 3 is a photograph of a reservation before treatment; the scar and acne mark removing beautifying liquid is matched with the needle roller for treatment, and the treatment is carried out once every two weeks for 4 times. Fig. 4 is a photograph of a post-treatment residue showing a clear lightening of the pits of both cheeks, a lightening of the pigmentation of the acne marks, a shrinking of the pores of the skin, and a finer and whiter appearance than before the treatment.
Case 3: some gold, men, 19 years old, students in Shanghai. For 2 years of history of acne, obvious concave acne pits are locally reserved, cystic acne is reserved at the lower jaw, the treatment is carried out in the hospital in the year 2020, and fig. 5 is a photograph of a reservation before the treatment; by adopting the scar and acne removing beautifying liquid disclosed by the invention and matching with the needle roller treatment, after four times of treatment, fig. 6 is a photograph of a post-treatment mark, it can be obviously seen that cystic acne is obviously reduced and removed, acne marks disappear, after three months, the acne marks are left for a plurality of new acnes of a patient, the patient is required to actively treat the acne marks for 2 times, fig. 7 and 8 are photographs of the post-treatment mark, and the acne marks are obviously removed, and the skin is smoother and tighter than before.
While the invention has been described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that various modifications and additions may be made without departing from the scope of the invention. Equivalent embodiments of the present invention will be apparent to those skilled in the art having the benefit of the teachings disclosed herein, when considered in the light of the foregoing disclosure, and without departing from the spirit and scope of the invention; meanwhile, any equivalent changes, modifications and evolution of the above embodiments according to the essential technology of the present invention still fall within the scope of the technical solution of the present invention.
Claims (5)
1. The application of the scar and acne mark removing cosmetic liquid in preparing the microneedle base liquid comprises the following component raw materials in percentage by weight: 3.5 to 20 percent of centella asiatica extract, 1.5 to 10 percent of honeysuckle extract, 1.5 to 10 percent of campsis grandiflora extract, 5.0 to 20.0 percent of alanyl glutamine, 15 to 55 percent of glycerate acrylate/acrylic acid copolymer, 1.0 to 4.0 percent of PVM/MA copolymer, 0.1 to 1.0 percent of glycerol, 0.01 to 0.15 percent of methylparaben, 0.01 to 0.05 percent of propylparaben and 35 to 55 percent of deionized water.
2. The use according to claim 1, wherein the cosmetic liquid comprises the following raw materials in percentage by weight: 10% of centella asiatica extract, 3.5% of honeysuckle extract, 3.5% of campsis grandiflora extract, 10% of alanyl glutamine, 25% of glycerol acrylic ester/acrylic acid copolymer, 2.0% of PVM/MA copolymer, 0.5% of glycerol, 0.05% of methylparaben, 0.03% of propylparaben and 45.42% of deionized water.
3. The use according to any one of claims 1 to 2, wherein the preparation method of the cosmetic liquid comprises the steps of:
s1, stirring centella asiatica extract, honeysuckle extract, campsis grandiflora extract and alanyl glutamine to obtain a first mixture;
s2, stirring the glycerol acrylate/acrylic acid copolymer, PVM/MA copolymer, glycerol, methylparaben, propylparaben and deionized water to obtain a second mixture;
and S3, mixing the first mixture obtained in the step S1 and the second mixture obtained in the step S2, and stirring the mixture uniformly to obtain the scar and acne mark removing cosmetic liquid.
4. The use of claim 3, further comprising one or more of the following features:
(1) In the step S1, the stirring speed is 60-150 rpm, and the stirring time is 0.5-1 h;
(2) In the step S2, the stirring speed is 100-200 rpm, and the stirring time is 0.5-1 h;
(3) And in the step S3, the stirring speed is 100-200 rpm, and the stirring time is 0.5-1 h.
5. The use according to any one of claims 1-2, wherein the cosmetic liquid has the following efficacy: 1) Skin pit scar repair; 2) Acne print pigmentation is reduced; 3) Cyst type acne detumescence and stagnation elimination; 4) Inhibit acne scar formation and hyperplasia.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210420975.4A CN114767590B (en) | 2022-04-20 | 2022-04-20 | Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210420975.4A CN114767590B (en) | 2022-04-20 | 2022-04-20 | Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114767590A CN114767590A (en) | 2022-07-22 |
CN114767590B true CN114767590B (en) | 2024-03-15 |
Family
ID=82431318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210420975.4A Active CN114767590B (en) | 2022-04-20 | 2022-04-20 | Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114767590B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103002903A (en) * | 2010-06-28 | 2013-03-27 | Ade治疗公司 | Keloid treatment |
CN109646356A (en) * | 2019-01-30 | 2019-04-19 | 邯郸市丛台区本草汉方贸易有限公司 | Chinese medicine composition, its purposes and facial mask |
CN111419757A (en) * | 2020-04-30 | 2020-07-17 | 南京苗邦美业企业管理有限公司 | Herbal skin-care essence |
-
2022
- 2022-04-20 CN CN202210420975.4A patent/CN114767590B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103002903A (en) * | 2010-06-28 | 2013-03-27 | Ade治疗公司 | Keloid treatment |
CN109646356A (en) * | 2019-01-30 | 2019-04-19 | 邯郸市丛台区本草汉方贸易有限公司 | Chinese medicine composition, its purposes and facial mask |
CN111419757A (en) * | 2020-04-30 | 2020-07-17 | 南京苗邦美业企业管理有限公司 | Herbal skin-care essence |
Also Published As
Publication number | Publication date |
---|---|
CN114767590A (en) | 2022-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109157451B (en) | Acne-removing facial cleanser | |
EP0738516A1 (en) | External preparation for skin protection | |
CN107375032B (en) | Composition for repairing skin barrier and preparation method thereof | |
CN109260075B (en) | Acne-removing conditioning water | |
CN108653129B (en) | Skin dressing containing natural plant anti-allergy composition | |
US7655255B2 (en) | Topical composition for transdermal administration | |
CN111588815B (en) | External acne-removing traditional Chinese medicine composition, application thereof and acne-removing balancing essence containing composition | |
US20060222689A1 (en) | Skin care compositions and methods | |
CN111773272A (en) | External compound formula for treating acne and preparation method thereof | |
KR102141574B1 (en) | Cosmetic Composition for Scalp Care and Method of Manufacturing the same | |
CN111671692A (en) | Acne-removing composition and preparation method and application thereof | |
CN111529450A (en) | Deep moisturizing repair composition, skin care product and preparation method thereof | |
CN112516066B (en) | Oil control composition and application thereof in cosmetics | |
US20020176876A1 (en) | Topical therapeutic skin care system | |
CN116459169B (en) | Anti-inflammatory moisturizing skin external composition and preparation method and application thereof | |
CN102335231B (en) | Chinese medicinal moisturizing cream for treating chloasma as well as preparation method and application thereof | |
CN114767590B (en) | Scar-removing acne mark-removing beautifying liquid and preparation method and application thereof | |
CN108721154B (en) | Skin care product for skin moisturizing and barrier repair and preparation method thereof | |
DE69005160T2 (en) | Use of 5'-deoxy-5'-methylthioadenosine, s-adenylmethionine and their salts for the production of pharmaceutical preparations for promoting hair growth in patients with baldness. | |
CN106511153B (en) | Nanometer composition with acne removing effect and cosmetic or skin care product thereof | |
CN109568230A (en) | A kind of Chinese medicine cosmetic of the anti-aging of moisturizing whitening | |
EP1752132A2 (en) | Skin cosmetic compositions | |
CN113925825A (en) | Facial essence and preparation method thereof | |
CN113081933A (en) | Acne-removing composition and preparation method and application thereof | |
CN112807238A (en) | Anti-inflammatory and soothing repair gel for skin and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |